These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38754054)

  • 21. Histologic transformation of benign endometriosis to early epithelial ovarian cancer.
    Sainz de la Cuesta R; Eichhorn JH; Rice LW; Fuller AF; Nikrui N; Goff BA
    Gynecol Oncol; 1996 Feb; 60(2):238-44. PubMed ID: 8631545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
    Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
    Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.
    Zhou Q; Zhu C; Shen Z; Zhang T; Li M; Zhu J; Qin J; Xie Y; Zhang W; Chen R; Wang G; Qian L; Wu D; Nashan B; Zhou Y
    Eur J Surg Oncol; 2020 May; 46(5):855-861. PubMed ID: 32001042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300 000 Norwegian women.
    Licaj I; Jacobsen BK; Selmer RM; Maskarinec G; Weiderpass E; Gram IT
    Br J Cancer; 2017 Jan; 116(2):270-276. PubMed ID: 27959888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
    Morency E; Leitao MM; Soslow RA
    Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of ovarian endometriosis in epithelial ovarian cancer.
    Jimbo H; Yoshikawa H; Onda T; Yasugi T; Sakamoto A; Taketani Y
    Int J Gynaecol Obstet; 1997 Dec; 59(3):245-50. PubMed ID: 9486515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endometriosis as a risk factor for ovarian cancer].
    Vargas-Hernández VM
    Cir Cir; 2013; 81(2):163-8. PubMed ID: 23522320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study.
    Shim SH; Lim J; Kim JH; Lee YJ; Ha HI; Lim MC; Won YJ
    J Gynecol Oncol; 2024 May; 35(3):e32. PubMed ID: 38130136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ovarian carcinoma. Do the subtypes reflect different diseases?].
    Köbel M
    Pathologe; 2008 Nov; 29 Suppl 2():160-2. PubMed ID: 18709371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for epithelial ovarian cancer by histologic subtype.
    Gates MA; Rosner BA; Hecht JL; Tworoger SS
    Am J Epidemiol; 2010 Jan; 171(1):45-53. PubMed ID: 19910378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiologic features of borderline ovarian tumors in California: a population-based study.
    Morris CR; Liu L; Rodriguez AO; Cress RD; Snipes K
    Cancer Causes Control; 2013 Apr; 24(4):665-74. PubMed ID: 23314731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma.
    Fujimura M; Hidaka T; Kataoka K; Yamakawa Y; Akada S; Teranishi A; Saito S
    Am J Surg Pathol; 2001 May; 25(5):667-72. PubMed ID: 11342781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism.
    Niemi RJ; Braicu EI; Kulbe H; Koistinen KM; Sehouli J; Puistola U; Mäenpää JU; Hilvo M
    Br J Cancer; 2018 Oct; 119(7):847-854. PubMed ID: 30293997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A serum based analysis of ovarian epithelial tumorigenesis.
    Nolen B; Marrangoni A; Velikokhatnaya L; Prosser D; Winans M; Gorelik E; Lokshin A
    Gynecol Oncol; 2009 Jan; 112(1):47-54. PubMed ID: 19007974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for ovarian cancers with and without microsatellite instability.
    Segev Y; Pal T; Rosen B; McLaughlin JR; Sellers TA; Risch HA; Zhang S; Ping S; Narod SA; Schildkraut J
    Int J Gynecol Cancer; 2013 Jul; 23(6):1010-5. PubMed ID: 23748177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas.
    Matsuo K; Matsuzaki S; Maeda M; Rau AR; Yoshihara K; Tamura R; Shimada M; Machida H; Mikami M; Klar M; Roman LD; Wright JD; Sood AK; Gershenson DM
    JAMA Netw Open; 2023 Jun; 6(6):e2318602. PubMed ID: 37326992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for different histological types of ovarian cancer.
    Parazzini F; Chiaffarino F; Negri E; Surace M; Benzi G; Franceschi S; Fedele L; La Vecchia C
    Int J Gynecol Cancer; 2004; 14(3):431-6. PubMed ID: 15228415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study.
    Hannibal CG; Frederiksen K; Vang R; Kurman RJ; Kjaer SK
    Int J Cancer; 2020 Aug; 147(4):990-995. PubMed ID: 31930502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.